Invitro International IVRO:OTCPK

RT Quote | Exchange | USD
Last | 06/30/22 EDT
0.07UNCH (UNCH)
52 week range
0.06 - 0.51
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.07
  • 52 Week High0.51
  • 52 Week High Date12/31/21
  • 52 Week Low0.06
  • 52 Week Low Date05/16/22

Key Stats

  • Market Cap1.59M
  • Shares Out22.76M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.38
  • YTD % Change-72

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.07
  • 52 Week High0.51
  • 52 Week High Date12/31/21
  • 52 Week Low0.06
  • 52 Week Low Date05/16/22
  • Market Cap1.59M
  • Shares Out22.76M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.38
  • YTD % Change-72

RATIOS/PROFITABILITY

  • EPS (TTM)0.00
  • P/E (TTM)200.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-13,180.00
  • ROE (TTM)1.09%
  • Revenue (TTM)720,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)0.87%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Invitro International

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
InVitro International, Inc. is a customer and technology-driven provider of non-animal testing methods. The Company produces and sells in vitro assay kits to detect, rank and predict the level of irritancy, toxicity or corrosivity of substances on human eye (ocular) and/or skin tissue (dermal). The Company has three vitro products: Ocular Irritection used to evaluate the potential for ocular irritation; Irritection Dermal used to evaluate the potential for dermal irritation...
Irwin Gruverman
Chairman of the Board
W. Richard Ulmer
President, Chief Executive Officer, Director
Address
330 E Orangethorpe Ave Ste D
Placentia, CA
92870-6503
United States